Frontiers Health 2026

Reimagining Global Commercialisation

20-21 October, Berlin, Germany

We are the global commercialisation partner reimagining how life sciences companies bring innovations to market – driven by data, human expertise, powered by AI, and committed to improving patient outcomes worldwide.
 
Request a meeting with one of our commercialisation experts to explore the next frontier of innovation in life sciences!
 

SCHEDULE A MEETING


Engage in Expert-Led Sessions

Discover strategies to accelerate global access and patient impact.

The New Commercialization Imperative: Turning Innovation into Patient Impact [Plenary]

  • Mike Ryan, President, Europe, EVERSANA
  • Felipe Florez-Arango, CEO, Helvion Pharma
  • Stefan Zillikens MSc, PhD, Cogent HealthCare GmbH 

Death of a Salesman. The Birth of Omnideployment

  • James May, Global Media Lead, EVERSANA
  • Dan Feldman, SVP, Strategy & Development – UK, EU & APAC, EVERSANA
  • Tim Rubesam, VP, Head of Global Marketing, Biotest

How Agentic AI Makes Behavioural Science Available to Everyone

  • Harriet Painter, VP, MedComms, EVERSANA
  • Michael Le Brocq, SVP, Head of Global Strategy, EVERSANA
  • Alexane Gurwic, Independent Advisor, Digital Health & Customer Engagement
  • Natasha Hansjee, Integrated Medical Engagement Catalyst, Roche Global Medical Affairs

The Rise of Digital-First Access Pathways in Europe

  • Alberta Spreafico, SVP, Health Innovation, EVERSANA
  • Nico Hribernik, Co-Founder and CEO, Wellster
  • Martin Moller Paarse, CEO, Liva Healthcare

Our Latest Insights on Key Industry Topics

EVERSANA Back as Frontiers Health Global Host & Presenting Sponsor

How IRA, MFN, and HTA are rewriting oncology launch strategy

One Year of EVERSANA’s AI Agency: What We Learned at Google’s New York Headquarters

Navigating the Intersection of AI, Global Commercialization and Patient Value